Christina Sze1,2, Efrat Tsivian3, Kae Jack Tay3,4, Ariel A Schulman3, Leah G Davis3, Rajan T Gupta3,5, Thomas J Polascik3. 1. Urologic Surgery, Duke University Medical Center and the Duke Cancer Institute, Durham, NC, USA. christina.sze89@gmail.com. 2. Division of Urology, Department of Surgery, Duke University Medical Center, Box 2804, Yellow Zone, Durham, NC, 27710, USA. christina.sze89@gmail.com. 3. Urologic Surgery, Duke University Medical Center and the Duke Cancer Institute, Durham, NC, USA. 4. Singapore General Hospital, Singapore, Singapore. 5. Department of Radiology, Duke University Medical Center, Durham, NC, USA.
Abstract
BACKGROUND: Due to their location away from the nerve bundles, anterior prostate cancers (APC) represent a rational target for image-guided cryoablation. This report describes the feasibility and short-term outcomes of anterior focal cryosurgery. METHODS: A retrospective review between 2012 and 2016 of patients with clinically localized APC treated with anterior gland cryoablation was performed. Descriptive statistics were used to report: age, PSA, prostate volume, prostate cancer grade group (PGG), median time to follow-up, and changes in functional status measured with the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF-5) score. RESULTS: A total of 17 patients underwent anterior focal cryoablation with a median follow-up of 15 months. Median age and PSA at diagnosis were 67 years and 8.7 ng/mL. Pre-operative PGG1 was identified in 12 (71%) men and PGG2 in 5 (29%) men. Median (IQR) lesion volume was 2 mL(0.86, 3.1). Preoperative median IIEF-5 and IPSS scores were 19.5 and 5, and decreased to 19 and 4, post-operatively. All patients remained continent with no change in sexual function. All post-procedure targeted biopsies of the treated cancers were negative. CONCLUSION: Our pilot study demonstrates the feasibility of treating APCs with image-guided targeted focal cryoablation as a good balance between short-term oncologic control and near complete preservation of genitourinary function. Further follow-up is necessary to examine the potential benefits long-term.
BACKGROUND: Due to their location away from the nerve bundles, anterior prostate cancers (APC) represent a rational target for image-guided cryoablation. This report describes the feasibility and short-term outcomes of anterior focal cryosurgery. METHODS: A retrospective review between 2012 and 2016 of patients with clinically localized APC treated with anterior gland cryoablation was performed. Descriptive statistics were used to report: age, PSA, prostate volume, prostate cancer grade group (PGG), median time to follow-up, and changes in functional status measured with the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF-5) score. RESULTS: A total of 17 patients underwent anterior focal cryoablation with a median follow-up of 15 months. Median age and PSA at diagnosis were 67 years and 8.7 ng/mL. Pre-operative PGG1 was identified in 12 (71%) men and PGG2 in 5 (29%) men. Median (IQR) lesion volume was 2 mL(0.86, 3.1). Preoperative median IIEF-5 and IPSS scores were 19.5 and 5, and decreased to 19 and 4, post-operatively. All patients remained continent with no change in sexual function. All post-procedure targeted biopsies of the treated cancers were negative. CONCLUSION: Our pilot study demonstrates the feasibility of treating APCs with image-guided targeted focal cryoablation as a good balance between short-term oncologic control and near complete preservation of genitourinary function. Further follow-up is necessary to examine the potential benefits long-term.
Entities:
Keywords:
Anterior gland; Continence; Erectile function; Focal cryoablation; Prostate cancer
Authors: Melissa H Mendez; Niccolo Maria Passoni; Julio Pow-Sang; J Stephen Jones; Thomas J Polascik Journal: J Endourol Date: 2015-07-13 Impact factor: 2.942
Authors: J Mygatt; I Sesterhenn; I Rosner; Y Chen; J Cullen; T Morris-Gore; J Barton; A Dobi; S Srivastava; D McLeod; S A Brassell Journal: Prostate Cancer Prostatic Dis Date: 2013-12-03 Impact factor: 5.554
Authors: Hikmat A Al-Ahmadie; Satish K Tickoo; Semra Olgac; Anuradha Gopalan; Peter T Scardino; Victor E Reuter; Samson W Fine Journal: Am J Surg Pathol Date: 2008-02 Impact factor: 6.394
Authors: Jan P Radtke; Constantin Schwab; Maya B Wolf; Martin T Freitag; Celine D Alt; Claudia Kesch; Ionel V Popeneciu; Clemens Huettenbrink; Claudia Gasch; Tilman Klein; David Bonekamp; Stefan Duensing; Wilfried Roth; Svenja Schueler; Christian Stock; Heinz-Peter Schlemmer; Matthias Roethke; Markus Hohenfellner; Boris A Hadaschik Journal: Eur Urol Date: 2016-01-19 Impact factor: 20.096
Authors: Maarten de Rooij; Simone Crienen; J Alfred Witjes; Jelle O Barentsz; Maroeska M Rovers; Janneke P C Grutters Journal: Eur Urol Date: 2013-12-21 Impact factor: 20.096
Authors: Lars Egevad; Brett Delahunt; David G Bostwick; Liang Cheng; Andrew J Evans; Troy Gianduzzo; Markus Graefen; Jonas Hugosson; James G Kench; Katia R M Leite; Jon Oxley; Guido Sauter; John R Srigley; Pär Stattin; Toyonori Tsuzuki; John Yaxley; Hemamali Samaratunga Journal: BJU Int Date: 2020-11-27 Impact factor: 5.588